News

  • 11 July 2019

    Boehringer reports positive data for dabigatran in children

    Boehringer Ingelheim has reported positive data from two clinical trials that investigated dabigatran etexilate, a direct oral anticoagulant (DOAC), for the treatment and prevention of recurrent venous thromboembolism (VTE) in...

Close
Close
Close

Go Top